TY  - JOUR
AU  - Remon, J
AU  - García-Campelo, R
AU  - de Álava, E
AU  - Vera, R
AU  - Rodríguez-Peralto, J L
AU  - Rodríguez-Lescure, Á
AU  - Bellosillo, B
AU  - Garrido, P
AU  - Rojo, F
AU  - Álvarez-Alegret, R
PY  - 2019
DO  - 10.1007/s12094-019-02211-x
UR  - http://hdl.handle.net/10668/14556
T2  - Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
AB  - The proportion of cancer patients with tumours that harbour a potentially targetable genomic alteration is growing considerably. The diagnosis of these genomic alterations can lead to tailored treatment at the onset of disease or on progression and to...
LA  - en
KW  - Genomic profiling
KW  - Liquid biopsy
KW  - Oncology
KW  - Precision medicine
KW  - ctDNA
KW  - Biomarkers, Tumor
KW  - Consensus
KW  - Genomics
KW  - Humans
KW  - Liquid Biopsy
KW  - Medical Oncology
KW  - Neoplasms
KW  - Precision Medicine
KW  - Reproducibility of Results
KW  - Spain
TI  - Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
TY  - research article
VL  - 22
ER  -